Company filings profile · CIK 0001833214
SAB Biotherapeutics, Inc. — SEC filings & insider activity.
Real, source-linked SEC EDGAR activity for SAB Biotherapeutics, Inc. (SABS): 11 filings in the last 90 days vs 24 in the prior 90 (filing-velocity cooling ↓ · 0.46×). Latest material 8-K events, insider Form-4 transactions, and periodic reports — monitored for change.
✔ Verified against the public SEC EDGAR filing record as of Jun 21, 2026. Source-linked, daily-refreshed.
Material 8-K events — SAB Biotherapeutics, Inc.
8-K disclosures decoded by item code (the material events: agreements, results, control/management changes, impairments, restatements).
| Filed | Event | |
|---|---|---|
| Jun 18, 2026 | Item 5.07 | ↗ |
| May 4, 2026 | Entry into a Material Agreement; Financial Statements and Exhibits | ↗ |
| Apr 22, 2026 | Regulation FD Disclosure; Financial Statements and Exhibits | ↗ |
| Mar 19, 2026 | Entry into a Material Agreement; Other Events; Financial Statements and Exhibits | ↗ |
| Mar 10, 2026 | Regulation FD Disclosure; Other Events; Financial Statements and Exhibits | ↗ |
| Jan 12, 2026 | Regulation FD Disclosure; Financial Statements and Exhibits | ↗ |
| Jan 7, 2026 | Departure/Election of Directors or Officers; Regulation FD Disclosure; Financial Statements and Exhibits | ↗ |
| Dec 29, 2025 | Other Events | ↗ |
Watch SAB Biotherapeutics, Inc. automatically
Add this company to a watchlist and get a webhook/email the moment it files a material 8-K, an insider Form 4, or changes its risk-factor language.
Insider transactions (Form 4 / 3 / 5)
Recent filings
| Filed | Form | Detail | |
|---|---|---|---|
| Jun 18, 2026 | 8-K | Item 5.07 | ↗ |
| May 15, 2026 | SCHEDULE 13G/A | ↗ | |
| May 15, 2026 | SCHEDULE 13G | ↗ | |
| May 15, 2026 | SCHEDULE 13G | ↗ | |
| May 12, 2026 | 10-Q | 10-Q | ↗ |
| May 4, 2026 | 8-K | Entry into a Material Agreement; Financial Statements and Exhibits | ↗ |
| May 1, 2026 | SCHEDULE 13G | ↗ | |
| Apr 30, 2026 | DEF 14A | DEF 14A | ↗ |
| Apr 22, 2026 | 8-K | Regulation FD Disclosure; Financial Statements and Exhibits | ↗ |
| Mar 31, 2026 | S-8 | S-8 | ↗ |
| Mar 25, 2026 | 4 | 4 | ↗ |
| Mar 23, 2026 | SCHEDULE 13D/A | ↗ | |
| Mar 19, 2026 | 8-K | Entry into a Material Agreement; Other Events; Financial Statements and Exhibits | ↗ |
| Mar 19, 2026 | 424B5 | 424B5 | ↗ |
| Mar 17, 2026 | 424B5 | 424B5 | ↗ |
| Mar 11, 2026 | SCHEDULE 13D/A | ↗ | |
| Mar 10, 2026 | 8-K | Regulation FD Disclosure; Other Events; Financial Statements and Exhibits | ↗ |
| Mar 9, 2026 | 10-K | 10-K | ↗ |
| Feb 17, 2026 | SCHEDULE 13G/A | ↗ | |
| Feb 17, 2026 | SCHEDULE 13G/A | ↗ | |
| Feb 5, 2026 | 4 | 4 | ↗ |
| Feb 5, 2026 | 4 | 4 | ↗ |
| Feb 5, 2026 | 4 | 4 | ↗ |
| Feb 5, 2026 | 4 | 4 | ↗ |
| Feb 5, 2026 | 4 | 4 | ↗ |
| Jan 22, 2026 | SCHEDULE 13G | ↗ | |
| Jan 12, 2026 | 8-K | Regulation FD Disclosure; Financial Statements and Exhibits | ↗ |
| Jan 7, 2026 | EFFECT | Item ; Item ; Item | ↗ |
| Jan 7, 2026 | 4 | 4 | ↗ |
| Jan 7, 2026 | 4 | 4 | ↗ |
| Jan 7, 2026 | 3 | 3 | ↗ |
| Jan 7, 2026 | 3 | 3 | ↗ |
| Jan 7, 2026 | 8-K | Departure/Election of Directors or Officers; Regulation FD Disclosure; Financial Statements and Exhibits | ↗ |
| Dec 29, 2025 | S-3 | S-3 | ↗ |
| Dec 29, 2025 | 8-K | Other Events | ↗ |
| Dec 18, 2025 | 4 | 4 | ↗ |
| Dec 18, 2025 | 4 | 4 | ↗ |
| Dec 18, 2025 | 4 | 4 | ↗ |
| Dec 18, 2025 | 4 | 4 | ↗ |
| Dec 18, 2025 | 4 | 4 | ↗ |